Todd Christopher Longsworth, General Counsel at NovoCure Ltd (NVCR), sold 38,748 shares at $50.15 ($1.9M) on 2019-01-25, disclosed to the SEC on 2019-01-28.
Open-market sale of $1.9M NVCR by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.15 | 15,000 | $722K | 37.8% |
| 2 | $50.15 | 11,874 | $595K | 31.1% |
| 3 | $50.15 | 11,874 | $595K | 31.1% |
| Total | $49.38 avg | 38,748 | $1.9M | 100% |
| Filing → |
| NVCR | SELL | 2021-03-10 | $629K | — | Filing → |
| NVCR | SELL | 2021-03-08 | $848K | — | Filing → |
| NVCR | SELL | 2021-03-04 | $716K | — | Filing → |